Metacognitive Training for Depression - Development and Evaluation of Treatment Modules to Reduce Suicidality

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010543

Enrollment

Registered

2016-08-23

Start date

2016-07-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33 F34

Interventions

Group 1: Metacognitive training for depression and suicidality (D-MCT and S-MCT), 6 sessions D-MCT and 2 sessions S-MCT, 8 sessions (60min), 2 x per week (intervention period 4 weeks). Informations ab

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of a depressive disorder

Exclusion criteria

Exclusion criteria: Age 65, existence of mood congruent (parathym) psychotic or manic symptoms

Design outcomes

Primary

Measure	Time frame
Primary outcome parameter is change of suicidality as measured by the Beck Scale for Suicide Ideation (BSS) from baseline (t0) to one month follow-up assessment (t2).	—

Secondary

Measure	Time frame
Secondary outcome parameters are change of depressive symptoms (as assessed by the Hamilton Depression Scale [HDRS] and Beck's Depression Inventory [BDI-II]) as well as the dysfunctional depressive and suicide specific (meta-) cognitive biases (e.g., Ruminative Response Scale [RRS], Beck Hopelessness Scale [BHS], Dysfunctional Attitude Scale [DAS], Metacognition Questionnaire [MCQ-30]. Further secondary outcome parameters are the Rosenberg Self-Esteem Scale [RSE], quality of life as measured by the World Health Organization Quality of Life Assessment [WHOQOL-BREF], stress coping strategies [BRIEF-COPE] as well as perfectionism identified with the questionnaire for measuring perfectionism [FMPS-D] and an Implicit Association Test (IAT) for perfectionism. Changes in the secondary outcome parameters compared from baseline (t0) to four weeks after treatment (t1) and one month follow-up assessment (t2) will be analyzed. Changes in suicidality as measured by the Beck Scale for Suicide Ideation (BSS) will be compared from baseline (t0) to after four weeks treatment (t1).	—

Measure

Time frame

Secondary outcome parameters are change of depressive symptoms (as assessed by the Hamilton Depression Scale [HDRS] and Beck's Depression Inventory [BDI-II]) as well as the dysfunctional depressive and suicide specific (meta-) cognitive biases (e.g., Ruminative Response Scale [RRS], Beck Hopelessness Scale [BHS], Dysfunctional Attitude Scale [DAS], Metacognition Questionnaire [MCQ-30]. Further secondary outcome parameters are the Rosenberg Self-Esteem Scale [RSE], quality of life as measured by the World Health Organization Quality of Life Assessment [WHOQOL-BREF], stress coping strategies [BRIEF-COPE] as well as perfectionism identified with the questionnaire for measuring perfectionism [FMPS-D] and an Implicit Association Test (IAT) for perfectionism. Changes in the secondary outcome parameters compared from baseline (t0) to four weeks after treatment (t1) and one month follow-up assessment (t2) will be analyzed. Changes in suicidality as measured by the Beck Scale for Suicide Ideation (BSS) will be compared from baseline (t0) to after four weeks treatment (t1).

—

Countries

Germany

Contacts

Public ContactLena Jelinek

Universitätsklinikum Hamburg-Eppendorf,Klinik für Psychiatrie und Psychotherapie

ljelinek@uke.de+49 40 7410-55868

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026